Protalix Biotherapeutics Inc
F:PBDA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Protalix Biotherapeutics Inc
F:PBDA
|
US |
Wall St Price Targets
PBDA Price Targets Summary
Protalix Biotherapeutics Inc
According to Wall Street analysts, the average 1-year price target for PBDA is 9.36 EUR with a low forecast of 8.42 EUR and a high forecast of 10.51 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PBDA's stock price target?
Price Target
9.36
EUR
According to Wall Street analysts, the average 1-year price target for PBDA is 9.36 EUR with a low forecast of 8.42 EUR and a high forecast of 10.51 EUR.
What is the Revenue forecast for Protalix Biotherapeutics Inc?
Projected CAGR
15%
Over the last 14 years, the compound annual growth rate for Revenue has been 23%. The projected CAGR for the next 2 years is 15%.
What is the Gross Profit forecast for Protalix Biotherapeutics Inc?
Projected CAGR
7%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 23%. The projected CAGR for the next 6 years is 7%.
